Colin Gross

Mining Exomic Sequencing Data to Identify Mutated Antigens Recognized by Adoptively Transferred Tumor-reactive T cells

Jimmy Lin, P. Cliften, J. Gartner, 2013, Nature Medicine.

CD8+ Enriched “Young” Tumor Infiltrating Lymphocytes Can Mediate Regression of Metastatic Melanoma

S. Rosenberg, D. Citrin, J. Yang, 2010, Clinical Cancer Research.

Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions

S. Rosenberg, Y. Samuels, J. Yang, 2014, Clinical Cancer Research.

Randomized selection design trial evaluating CD8+-enriched versus unselected tumor-infiltrating lymphocytes for adoptive cell therapy for patients with melanoma.

Seth M Steinberg, S. Steinberg, S. Rosenberg, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes

S. Rosenberg, J. Yang, M. Dudley, 2012, Journal of immunotherapy.